Exhibit 107
Calculation of Filing Fee Tables
SC TO-T
(Form Type)
Deciphera Pharmaceuticals, Inc.
(Name of Subject Company - Issuer)
Topaz Merger Sub, Inc.
(Names of Filing Persons - Offeror)
Ono Pharmaceutical Co., Ltd.
(Names of Filing Persons - Parent of Offeror)
Table 1: Transaction Valuation
Transaction Valuation | Fee Rate | Amount of Filing Fee | ||||
Fees to Be Paid | $2,426,954,563* | 0.00014760 | $358,218** | |||
Fees Previously Paid | $0.00 | $0.00 | ||||
Total Transaction Valuation | $2,426,954,563 | |||||
Total Fees Due for Filing | $358,218 | |||||
Total Fees Previously Paid | $0.00 | |||||
Total Fee Offsets | $0.00 | |||||
Net Fee Due | $358,218 |
* | The transaction valuation was estimated based on the sum of (a) the product of 82,225,972 shares of common stock issued and outstanding and $25.60 per share; (b) the product of 6,980,932 shares of common stock underlying outstanding options, with exercise prices less than $25.60, and $12.524, which is the difference between $25.60 and the weighted average exercise price of $13.076 per share of the underlying outstanding stock options; (c) the product of 3,085,820 shares of common stock underlying outstanding restricted stock unit awards and $25.60 per share; (d) the product of 530,544 shares of common stock underlying outstanding performance stock unit awards and $25.60 per share; (e) the product of 5,466,133 shares of common stock underlying outstanding pre-funded warrants, and $25.59, which is the difference between $25.60 and the weighted average exercise price of $0.01 per share of the underlying outstanding pre-funded warrants; and (f) the product of 81,376 shares of common stock estimated to be issued under the Company ESPP and $25.60 per share. The calculation of the filing fee is based on information provided by Deciphera Pharmaceuticals, Inc. as of April 24, 2024. |
** | The amount of the filing fee was calculated in accordance with Rule 0-11 of the Securities Exchange Act of 1934, as amended, and Fee Rate Advisory #1 for fiscal year 2024 beginning on October 1, 2023, issued on August 25, 2023, by multiplying the transaction valuation by 0.00014760. |